These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 33588913)

  • 1. A specific tRNA half, 5'tiRNA-His-GTG, responds to hypoxia via the HIF1α/ANG axis and promotes colorectal cancer progression by regulating LATS2.
    Tao EW; Wang HL; Cheng WY; Liu QQ; Chen YX; Gao QY
    J Exp Clin Cancer Res; 2021 Feb; 40(1):67. PubMed ID: 33588913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the role of tRNA-derived small RNAs (tsRNAs) in disease: implications for HIF-1 pathway modulation.
    Wang Q; Ying X; Huang Q; Wang Z; Duan S
    J Mol Med (Berl); 2024 Aug; 102(8):973-985. PubMed ID: 38850298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. tRNA-derived small RNA, 5'tiRNA-Gly-CCC, promotes skeletal muscle regeneration through the inflammatory response.
    Shen L; Liao T; Chen Q; Lei Y; Wang L; Gu H; Qiu Y; Zheng T; Yang Y; Wei C; Chen L; Zhao Y; Niu L; Zhang S; Zhu Y; Li M; Wang J; Li X; Gan M; Zhu L
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):1033-1045. PubMed ID: 36755335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5'tiRNA-Pro-TGG, a novel tRNA halve, promotes oncogenesis in sessile serrated lesions and serrated pathway of colorectal cancer.
    Wang XY; Zhou YJ; Chen HY; Chen JN; Chen SS; Chen HM; Li XB
    World J Gastrointest Oncol; 2023 Jun; 15(6):1005-1018. PubMed ID: 37389118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. tsRNA-GlyGCC promotes colorectal cancer progression and 5-FU resistance by regulating SPIB.
    Xu R; Du A; Deng X; Du W; Zhang K; Li J; Lu Y; Wei X; Yang Q; Tang H
    J Exp Clin Cancer Res; 2024 Aug; 43(1):230. PubMed ID: 39153969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
    Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
    Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor inhibiting HIF1α (FIH-1) functions as a tumor suppressor in human colorectal cancer by repressing HIF1α pathway.
    Chen T; Ren Z; Ye LC; Zhou PH; Xu JM; Shi Q; Yao LQ; Zhong YS
    Cancer Biol Ther; 2015; 16(2):244-52. PubMed ID: 25602156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. m
    Pereira M; Ribeiro DR; Pinheiro MM; Ferreira M; Kellner S; Soares AR
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis.
    Sun Z; Zhang Q; Yuan W; Li X; Chen C; Guo Y; Shao B; Dang Q; Zhou Q; Wang Q; Wang G; Liu J; Kan Q
    J Exp Clin Cancer Res; 2020 Nov; 39(1):250. PubMed ID: 33218358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression spectrum and targeted gene prediction of tRNA-derived small RNAs in idiopathic pulmonary arterial hypertension.
    Chen Y; Tang Y; Hou S; Luo J; Chen J; Qiu H; Chen W; Li K; He J; Li J
    Front Mol Biosci; 2023; 10():1204740. PubMed ID: 37496778
    [No Abstract]   [Full Text] [Related]  

  • 11. MiR-372-3p promotes tumor progression by targeting LATS2 in colorectal cancer.
    Peng H; Pan X; Su Q; Zhu LS; Ma GD
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8332-8344. PubMed ID: 31646563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfer RNA-derived small RNAs (tsRNAs) sequencing revealed a differential expression landscape of tsRNAs between glioblastoma and low-grade glioma.
    Tu M; Zuo Z; Chen C; Zhang X; Wang S; Chen C; Sun Y
    Gene; 2023 Mar; 855():147114. PubMed ID: 36526122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the regulatory role of tsRNAs in the TNF signaling pathway: Implications for cancer and non-cancer diseases.
    Wang Q; Huang Q; Ying X; Zhou Y; Duan S
    Prog Biophys Mol Biol; 2024 Sep; 191():1-10. PubMed ID: 38971324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of hippo pathway in colorectal cancer.
    Liang K; Zhou G; Zhang Q; Li J; Zhang C
    Saudi J Gastroenterol; 2014; 20(3):188-94. PubMed ID: 24976283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The circular RNA circ-ERBIN promotes growth and metastasis of colorectal cancer by miR-125a-5p and miR-138-5p/4EBP-1 mediated cap-independent HIF-1α translation.
    Chen LY; Wang L; Ren YX; Pang Z; Liu Y; Sun XD; Tu J; Zhi Z; Qin Y; Sun LN; Li JM
    Mol Cancer; 2020 Nov; 19(1):164. PubMed ID: 33225938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase.
    Ma B; Chen Y; Chen L; Cheng H; Mu C; Li J; Gao R; Zhou C; Cao L; Liu J; Zhu Y; Chen Q; Wu S
    Nat Cell Biol; 2015 Jan; 17(1):95-103. PubMed ID: 25438054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrine promotes apoptosis in SW480 colorectal cancer cells via elevating MIEF1-related mitochondrial division in a manner dependent on LATS2-Hippo pathway.
    Zhang Y; Wang M; Xu X; Liu Y; Xiao C
    J Cell Physiol; 2019 Dec; 234(12):22731-22741. PubMed ID: 31119752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
    Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
    Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of TXNDC5 in tumorigenesis of colorectal cancer cells: In vivo and in vitro evidence.
    Tan F; Zhu H; He X; Yu N; Zhang X; Xu H; Pei H
    Int J Mol Med; 2018 Aug; 42(2):935-945. PubMed ID: 29749460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.
    Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q
    J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.